Kalb Michael Wayne bought CPRX
November 21, 2025 · Form 4 insider transaction
Kalb Michael Wayne bought 6,894 shares of Catalyst Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,894
Price
N/A
Total value
N/A
InsiderKalb Michael Wayne
Role—
SecurityCommon Stock, par value $0.001 per share
Transaction codeM: Option exercise
Transaction dateNovember 21, 2025
Filing dateNovember 24, 2025
Shares owned after11,091
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.